Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » Opal Biosciences Sydney Wholesale Investor September 2015
Opal Biosciences Sydney Wholesale Investor September 2015
September 30, 2015 •
Category
•
Autor Name
Latest News
Results of General Meeting and 2016 CPS Meeting
September 9, 2024
240909_BDM_AGM_ResultsofMeeting_Shareholders_Final
Read More
BioDiem Notice of General Meeting and Proxy Form
August 16, 2024
BioDiem Notice of General Meeting and Proxy Form
Read More
